Skip to main content
. 2017 Oct 24;6(10):e005610. doi: 10.1161/JAHA.117.005610

Table 1.

Baseline General Characteristics of the 53 065 Individuals Selected for Study

Variables Total Sample (N=53 065) Years of Exposure to cumhs‐CRP η2 P Value
Nonexposed (N=29 496) 1‐Exposed (N=14 433) 2‐Exposed (N=6147) 3‐Exposed (N=2989)
Male, n (%) 40 433 (76.2) 22 538 (76.4) 11 770 (77.4) 4629 (75.3) 2096 (70.1) 0.001 <0.001
Age, y 49.00±11.73 47.47±11.34 48.86±11.68 53.36±11.69 55.79±11.15 0.044 <0.001
Baseline SBP, mm Hg 128.41±19.79 126.48±18.97 128.92±19.79 133.36±21.09 134.74±21.53 0.019 <0.001
Baseline DBP, mm Hg 82.64±11.35 81.72±11.04 83.16±11.45 84.82±11.85 84.72±11.87 0.010 <0.001
BMI, kg/m2 25.07±3.47 24.63±3.13 25.35±3.45 25.92±3.64 26.28±3.93 0.024 <0.001
FPG, mmol/L 5.39±1.54 5.34±1.42 5.43±1.55 5.47±1.75 5.52±2.01 0.001 <0.001
TC, mmol/L 4.93±1.14 4.88±1.14 4.94±1.15 5.02±1.07 5.09±1.07 0.003 <0.001
Current smokers, n (%) 15 841 (29.9) 9233 (31.3) 4519 (31.3) 1498 (24.4) 591 (19.8) 0.005 <0.001
Current drinkers, n (%) 9729 (17.5) 5552 (18.8) 2545 (17.6) 865 (14.1) 317 (10.6) 0.003 <0.001
Physical activity, n (%) 7301 (13.8) 4295 (14.6) 1940 (13.4) 761 (12.4) 305 (10.2) 0.001 <0.001
Hypertension, n (%) 20 495 (38.6) 10 016 (34.0) 5825 (40.4) 3073 (50.0) 1581 (52.9) 0.017 <0.001
Diabetes mellitus, n (%) 4131 (7.8) 1598 (6.6) 1192 (8.3) 640 (10.4) 341 (11.4) 0.003 <0.001
Hyperlipidemia, n (%) 39 937 (75.3) 22 002 (74.6) 11 245 (77.9) 4565 (74.3) 2125 (71.1) 0.002 <0.001
Antihypertensive medication, n (%) 9364 (45.7) 4313 (43.1) 2681 (46.0) 1513 (49.2) 857 (54.2) 0.003 <0.001
Antidiabetic medication, n (%) 2697 (65.3) 1159 (72.5) 759 (63.7) 486 (75.9) 293 (85.9) <0.001 <0.001
Lipid‐lowering medication, n (%) 1169 (2.9) 543 (2.5) 325 (2.9) 189 (4.1) 112 (5.3) <0.001 0.157

Continuous variables are presented as mean±SD; categorical variables are presented as numbers or percentages. Baseline DBP, diastolic blood pressure in 2006; Baseline SBP, systolic blood pressure in 2006; BMI, body mass index; cumhs‐CRP, cumulative high‐sensitivity C‐reactive protein; FPG, fasting plasma glucose; TC, total cholesterol.